Cancer Testing
🔬 FDA-Approved
Actionable gold-standard liquid biopsy analysis.
🧬 139 Genes
Comprehensive hereditary cancer genetic profiling.
📊 Risk Assessment
Early-stage detection aiding key therapy decisions.
🌐 Accredited Labs
Processed by elite clinical molecular networks.
The Value of Knowing For Sure
The genes we are born with could be a factor in contributing to our risk of developing certain types of cancer. If there is a history of cancer in your family, Clearbridge Medical endeavors to guide you in understanding your risk for disease. We offer cancer screening and testing and can assist you in making informed medical decisions.
Cell Search® CTC Test
Exclusively performed by SAM Clinical Laboratory in Southeast Asia, the Cellsearch® (CTC) Test is the only FDA-approved test for enumerating CTCs. It is an actionable test that assists healthcare professionals in the assessment of patients with metastatic breast, prostate or colorectal cancer.
Learn More ➔Hereditary Cancer Test
The test is a cancer diagnostic tool that gives a comprehensive analysis of 139 genes associated with the most common hereditary cancers: brain, breast, colorectal, kidney, leukemia, liver, lung, melanoma, pancreatic, prostate, ovarian, stomach, thyroid and uterine.
Learn More ➔
Prosigna
Now included in the International Clinical Practice Guidelines, Prosigna by Nanostring detects early stage breast cancer in patients through a highly accurate, FDA-approved risk assessment test.
Learn More ➔Take Control of Your Health
Get in touch with our clinical experts to schedule an assessment or discuss genetic screening options.
BOOK A CONSULTATION